-
Identification_of_drug_resistance_genes_in_melanoma_by_mRNA_gene_expression
Study
EGAS00001000815
-
Single-cell RNA sequencing of 22 Hodgkin lymphoma tumors and 5 reactive lymph nodes
Study
EGAS00001004085
-
PRADO trial - Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab plus nivolumab in stage III melanoma
Study
EGAS00001007601
-
Human melanoma samples with and without resistance to BRAF inhibitor therapy
Study
EGAS00001000992
-
Genomic and transcriptomic landscape of T-cell lymphoblastic lymphoma compared to T-cell acute lymphoblastic leukemia: similar subtypes and different fusions
Study
EGAS00001007767
-
Neuroblastoma tumor heterogeneity and cell plasticity (from PDX and cell lines)
Study
EGAS00001004781
-
NOTCH1 fusion genes in pediatric T-cell lymphoblastic lymphoma hallmark a common high-risk subgroup with blood TARC levels as possible biomarker
Study
EGAS00001007703
-
Volasertib preclinical activity in high-risk hepatoblastoma
Study
EGAS00001004827
-
Gene expression-based prediction of pazopanib efficacy in sarcoma (HIPO, H021)
Study
EGAS00001005836
-
Genomics-based characterization and personalized treatment in pleural and peritoneal mesothelioma
Study
EGAS00001007294
-
Total proteome and phosphoproteome profiling of Diffuse Midline Glioma
Study
EGAS00001007341
-
Methylproteome profiling of Diffuse Midline Glioma
Study
EGAS00001007342
-
Whole genome sequencing of patients with or at risk for HCC
Study
EGAS00001007249
-
'IL-17A-Producing ILC3s and Duodenal Adenoma in FAP'
Study
EGAS00001007347
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Genomic characterization of hepatocellular carcinoma in Hispanic patients
Study
EGAS00001007431
-
Myeloid cell programming in patients with non-medullary thyroid carcinoma
Study
EGAS00001005594
-
Single-cell RNA sequencing of 6 follicular lymphoma tumors
Study
EGAS00001005257
-
ExomeSeq Neoantigen Immunogenicity Landscapes
Study
EGAS00001007508
-
RNASeq Neoantigen Immunogenicity Landscape
Study
EGAS00001007509
-
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Study
EGAS00001003178
-
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Study
EGAS00001004165
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Transcriptomic analysis of the Phase 3 COMPARZ clinical trial
Study
EGAS00001004534
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
DIPG RNA and exome sequencing
Study
EGAS00001004749
-
G-SAM: Transcriptional Evolution of Glioblastomas Treated With Standard of Care
Study
EGAS00001005436
-
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Study
EGAS00001004349
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_squamous_cell_carcinoma
Study
EGAS00001002725
-
Pediatric HGG WES and RNA-Seq
Study
EGAS00001005687
-
Whole genome sequence and RNA-seq data from paired tumour and germline samples from mesothelioma patients.
Study
EGAS00001005196
-
Genomic landscape of malignant peripheral nerve sheath tumor (MPNST)
Study
EGAS00001006069
-
Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma
Study
EGAS00001006613
-
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Study
EGAS00001007404
-
Single-cell RNA sequencing on 5063 single T cells isolated from peripheral blood, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001002072
-
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Study
EGAS00001001632
-
Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study
Study
EGAS00001001709
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997
-
an integrated molecular study of clear cell renal cell carcinoma (ccRCC) including whole-genome/exome and RNA sequencing as well as array-based gene expression/copy-number/methylation analyses
Study
EGAS00001000509
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Study
EGAS00001004763
-
Whole genome and whole exome sequencing of serial biopsies of relapsed/refractory diffuse large B-cell lymphoma.
Study
EGAS00001007053
-
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Study
EGAS00001001653
-
Single-cell RNA sequencing on single CD45+ immune cells isolated from peripheral blood, lymphnode, ascites, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001003449
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Study
EGAS00001004422
-
Genome Landscape of Primary Pancreatic Ductal Adenocarcinoma
Study
EGAS00001000154
-
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH
Study
EGAS00001004285
-
Genome-wide discovery of somatic coding and regulatory variants in Diffuse Large B-cell Lymphoma
Study
EGAS00001002936
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
SPECIAL: Dissecting the melanoma ecosystem one cell at the time during immunotherapy
Study
EGAS00001006488
-
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Study
EGAS00001001024